These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1417 related articles for article (PubMed ID: 34129337)

  • 1. Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.
    Bahr G; González LJ; Vila AJ
    Chem Rev; 2021 Jul; 121(13):7957-8094. PubMed ID: 34129337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.
    Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A close look onto structural models and primary ligands of metallo-β-lactamases.
    Raczynska JE; Shabalin IG; Minor W; Wlodawer A; Jaskolski M
    Drug Resist Updat; 2018 Sep; 40():1-12. PubMed ID: 30466711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.
    Palacios AR; Rossi MA; Mahler GS; Vila AJ
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
    Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
    J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism Matters.
    Ju LC; Cheng Z; Fast W; Bonomo RA; Crowder MW
    Trends Pharmacol Sci; 2018 Jul; 39(7):635-647. PubMed ID: 29680579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
    Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A
    Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria.
    Davies DT; Everett M
    Acc Chem Res; 2021 May; 54(9):2055-2064. PubMed ID: 33788541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles and current strategies targeting metallo-β-lactamase mediated antibacterial resistance.
    Yan YH; Li G; Li GB
    Med Res Rev; 2020 Sep; 40(5):1558-1592. PubMed ID: 32100311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal Structure of the Metallo-β-Lactamase GOB in the Periplasmic Dizinc Form Reveals an Unusual Metal Site.
    Morán-Barrio J; Lisa MN; Larrieux N; Drusin SI; Viale AM; Moreno DM; Buschiazzo A; Vila AJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6013-22. PubMed ID: 27458232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.
    Brem J; van Berkel SS; Zollman D; Lee SY; Gileadi O; McHugh PJ; Walsh TR; McDonough MA; Schofield CJ
    Antimicrob Agents Chemother; 2016 Jan; 60(1):142-50. PubMed ID: 26482303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Peptide-based Metallo-β-lactamase Inhibitors as a New Strategy to Combat Antimicrobial Resistance: A Mini-review.
    Cheng Q; Zeng P; Chi Chan EW; Chen S
    Curr Pharm Des; 2022; 28(44):3538-3545. PubMed ID: 36177630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic Boronates Inhibit All Classes of β-Lactamases.
    Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in β-lactamase inhibitor chemotypes and inhibition modes.
    Li R; Chen X; Zhou C; Dai QQ; Yang L
    Eur J Med Chem; 2022 Nov; 242():114677. PubMed ID: 35988449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.
    Cain R; Brem J; Zollman D; McDonough MA; Johnson RM; Spencer J; Makena A; Abboud MI; Cahill S; Lee SY; McHugh PJ; Schofield CJ; Fishwick CWG
    J Med Chem; 2018 Feb; 61(3):1255-1260. PubMed ID: 29271657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Development of New Small-Molecule Inhibitors Targeting Bacterial Metallo-β-lactamases.
    Wang P; Cheng J; Liu CC; Tang K; Xu F; Yu Z; Yu B; Chang J
    Curr Top Med Chem; 2018; 18(10):834-843. PubMed ID: 29773066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding.
    Skagseth S; Akhter S; Paulsen MH; Muhammad Z; Lauksund S; Samuelsen Ø; Leiros HS; Bayer A
    Eur J Med Chem; 2017 Jul; 135():159-173. PubMed ID: 28445786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors.
    Wang R; Lai TP; Gao P; Zhang H; Ho PL; Woo PC; Ma G; Kao RY; Li H; Sun H
    Nat Commun; 2018 Jan; 9(1):439. PubMed ID: 29382822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.